These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19759093)

  • 21. Longitudinal progression of frontal and temporal lobe changes in schizophrenia.
    Cobia DJ; Smith MJ; Wang L; Csernansky JG
    Schizophr Res; 2012 Aug; 139(1-3):1-6. PubMed ID: 22647883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial.
    Eack SM; Hogarty GE; Cho RY; Prasad KM; Greenwald DP; Hogarty SS; Keshavan MS
    Arch Gen Psychiatry; 2010 Jul; 67(7):674-82. PubMed ID: 20439824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects.
    Bergé D; Carmona S; Rovira M; Bulbena A; Salgado P; Vilarroya O
    Acta Psychiatr Scand; 2011 Jun; 123(6):431-9. PubMed ID: 21054282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voxel-based morphometric analysis of gray matter in first episode schizophrenia.
    Kubicki M; Shenton ME; Salisbury DF; Hirayasu Y; Kasai K; Kikinis R; Jolesz FA; McCarley RW
    Neuroimage; 2002 Dec; 17(4):1711-9. PubMed ID: 12498745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
    Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
    J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia.
    Kasai K; Shenton ME; Salisbury DF; Hirayasu Y; Lee CU; Ciszewski AA; Yurgelun-Todd D; Kikinis R; Jolesz FA; McCarley RW
    Am J Psychiatry; 2003 Jan; 160(1):156-64. PubMed ID: 12505815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia.
    Vidal CN; Rapoport JL; Hayashi KM; Geaga JA; Sui Y; McLemore LE; Alaghband Y; Giedd JN; Gochman P; Blumenthal J; Gogtay N; Nicolson R; Toga AW; Thompson PM
    Arch Gen Psychiatry; 2006 Jan; 63(1):25-34. PubMed ID: 16389194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness.
    Tanskanen P; Ridler K; Murray GK; Haapea M; Veijola JM; Jääskeläinen E; Miettunen J; Jones PB; Bullmore ET; Isohanni MK
    Schizophr Bull; 2010 Jul; 36(4):766-77. PubMed ID: 19015212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insular cortex abnormalities in schizophrenia: Relationship to symptoms and typical neuroleptic exposure.
    Pressler M; Nopoulos P; Ho BC; Andreasen NC
    Biol Psychiatry; 2005 Feb; 57(4):394-8. PubMed ID: 15705355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progressive gray matter changes in first episode schizophrenia: a 4-year longitudinal magnetic resonance study using VBM.
    Mané A; Falcon C; Mateos JJ; Fernandez-Egea E; Horga G; Lomeña F; Bargalló N; Prats-Galino A; Bernardo M; Parellada E
    Schizophr Res; 2009 Oct; 114(1-3):136-43. PubMed ID: 19683418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional change in brain morphometry in schizophrenia associated with antipsychotic treatment.
    McClure RK; Phillips I; Jazayerli R; Barnett A; Coppola R; Weinberger DR
    Psychiatry Res; 2006 Dec; 148(2-3):121-32. PubMed ID: 17097276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naive, first-episode patients with schizophrenia.
    Guo X; Li J; Wang J; Fan X; Hu M; Shen Y; Chen H; Zhao J
    Schizophr Res; 2014 Feb; 152(2-3):339-43. PubMed ID: 24439000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.
    van Haren NE; Hulshoff Pol HE; Schnack HG; Cahn W; Mandl RC; Collins DL; Evans AC; Kahn RS
    Neuropsychopharmacology; 2007 Oct; 32(10):2057-66. PubMed ID: 17327887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia.
    Kaspárek T; Prikryl R; Mikl M; Schwarz D; Cesková E; Krupa P
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):151-7. PubMed ID: 17011096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study.
    Demjaha A; Galderisi S; Glenthøj B; Arango C; Mucci A; Lawrence A; O'Daly O; Kempton M; Ciufolini S; Baandrup L; Ebdrup BH; Rodriguez-Jimenez R; Diaz-Marsa M; Díaz-Caneja CM; Winter van Rossum I; Kahn R; Dazzan P; McGuire P
    Psychol Med; 2023 Jun; 53(8):3471-3479. PubMed ID: 35197142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis.
    Torres US; Portela-Oliveira E; Borgwardt S; Busatto GF
    BMC Psychiatry; 2013 Dec; 13():342. PubMed ID: 24359128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroanatomical pattern classification in a population-based sample of first-episode schizophrenia.
    Zanetti MV; Schaufelberger MS; Doshi J; Ou Y; Ferreira LK; Menezes PR; Scazufca M; Davatzikos C; Busatto GF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():116-25. PubMed ID: 23261522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anatomy of bipolar disorder and schizophrenia: a meta-analysis.
    Ellison-Wright I; Bullmore E
    Schizophr Res; 2010 Mar; 117(1):1-12. PubMed ID: 20071149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophrenia.
    Guo X; Li J; Wei Q; Fan X; Kennedy DN; Shen Y; Chen H; Zhao J
    PLoS One; 2013; 8(12):e83679. PubMed ID: 24391807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study.
    Bai YM; Chou KH; Lin CP; Chen IY; Li CT; Yang KC; Chou YH; Su TP
    Schizophr Res; 2009 Apr; 109(1-3):167-81. PubMed ID: 19261444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.